592 related articles for article (PubMed ID: 12857909)
1. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
2. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
[TBL] [Abstract][Full Text] [Related]
3. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
4. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
5. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Moss B
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
[TBL] [Abstract][Full Text] [Related]
6. Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.
Ludwig H; Suezer Y; Waibler Z; Kalinke U; Schnierle BS; Sutter G
J Gen Virol; 2006 May; 87(Pt 5):1145-1155. PubMed ID: 16603515
[TBL] [Abstract][Full Text] [Related]
7. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
Sutter G; Ramsey-Ewing A; Rosales R; Moss B
J Virol; 1994 Jul; 68(7):4109-16. PubMed ID: 8207789
[TBL] [Abstract][Full Text] [Related]
9. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
[TBL] [Abstract][Full Text] [Related]
10. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.
Drexler I; Heller K; Wahren B; Erfle V; Sutter G
J Gen Virol; 1998 Feb; 79 ( Pt 2)():347-52. PubMed ID: 9472619
[TBL] [Abstract][Full Text] [Related]
11. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.
Zhang P; Jacobs BL; Samuel CE
J Virol; 2008 Jan; 82(2):840-8. PubMed ID: 17959656
[TBL] [Abstract][Full Text] [Related]
12. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
13. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
Arsenio J; Deschambault Y; Cao J
Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
[TBL] [Abstract][Full Text] [Related]
14. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
[TBL] [Abstract][Full Text] [Related]
16. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
[TBL] [Abstract][Full Text] [Related]
17. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
[TBL] [Abstract][Full Text] [Related]
18. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
Wolferstätter M; Schweneker M; Späth M; Lukassen S; Klingenberg M; Brinkmann K; Wielert U; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2014 Dec; 88(24):14396-411. PubMed ID: 25297997
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
Waibler Z; Anzaghe M; Frenz T; Schwantes A; Pöhlmann C; Ludwig H; Palomo-Otero M; Alcamí A; Sutter G; Kalinke U
J Virol; 2009 Feb; 83(4):1563-71. PubMed ID: 19073732
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Deng L; Dai P; Ding W; Granstein RD; Shuman S
J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
